Find Umirolimus manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Biolimus a9, Trm 986, Trm-986, 42-o-(2-ethoxyethyl) rapamycin, 40-o-(2-ethoxyethyl)rapamycin, 851536-75-9
Molecular Formula
C55H87NO14
Molecular Weight
986.3  g/mol
InChI Key
YYSFXUWWPNHNAZ-PKJQJFMNSA-N
FDA UNII
U36PGF65JH

Umirolimus
1 2D Structure

Umirolimus

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-(2-ethoxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
2.1.2 InChI
InChI=1S/C55H87NO14/c1-12-67-26-27-68-45-24-22-41(31-48(45)65-10)30-37(5)47-33-44(57)36(4)29-39(7)50(59)51(66-11)49(58)38(6)28-34(2)18-14-13-15-19-35(3)46(64-9)32-42-23-21-40(8)55(63,70-42)52(60)53(61)56-25-17-16-20-43(56)54(62)69-47/h13-15,18-19,29,34,36-38,40-43,45-48,50-51,59,63H,12,16-17,20-28,30-33H2,1-11H3/b15-13+,18-14+,35-19+,39-29+/t34-,36-,37-,38-,40-,41+,42+,43+,45-,46+,47+,48-,50-,51+,55-/m1/s1
2.1.3 InChI Key
YYSFXUWWPNHNAZ-PKJQJFMNSA-N
2.1.4 Canonical SMILES
CCOCCOC1CCC(CC1OC)CC(C)C2CC(=O)C(C=C(C(C(C(=O)C(CC(C=CC=CC=C(C(CC3CCC(C(O3)(C(=O)C(=O)N4CCCCC4C(=O)O2)O)C)OC)C)C)C)OC)O)C)C
2.1.5 Isomeric SMILES
CCOCCO[C@@H]1CC[C@H](C[C@H]1OC)C[C@@H](C)[C@@H]2CC(=O)[C@@H](/C=C(/[C@H]([C@H](C(=O)[C@@H](C[C@@H](/C=C/C=C/C=C(/[C@H](C[C@@H]3CC[C@H]([C@@](O3)(C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)O)C)OC)\C)C)C)OC)O)\C)C
2.2 Other Identifiers
2.2.1 UNII
U36PGF65JH
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 40-o-(2-ethoxyethyl)rapamycin

2. 42-o-(2-ethoxyethyl) Rapamycin

3. Biolimus A9

4. Rapamycin, 42-o-(2-ethoxyethyl)-

5. Trm-986

2.3.2 Depositor-Supplied Synonyms

1. Biolimus A9

2. Trm 986

3. Trm-986

4. 42-o-(2-ethoxyethyl) Rapamycin

5. 40-o-(2-ethoxyethyl)rapamycin

6. 851536-75-9

7. Rapamycin, 42-o-(2-ethoxyethyl)-

8. U36pgf65jh

9. Biolimus-a9

10. A9

11. Umirolimus [inn]

12. Umirolimus [usan:inn]

13. Umirolimus [usan]

14. Unii-u36pgf65jh

15. Umirolimus [who-dd]

16. Ba-9

17. Trm986

18. Chembl2107380

19. Schembl17117902

20. Ex-a3593

21. Zinc169677041

22. Db15527

23. Hy-122402

24. Cs-0085037

25. Q7881588

26. A-9

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 986.3 g/mol
Molecular Formula C55H87NO14
XLogP36.8
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count14
Rotatable Bond Count11
Exact Mass985.61265645 g/mol
Monoisotopic Mass985.61265645 g/mol
Topological Polar Surface Area194 Ų
Heavy Atom Count70
Formal Charge0
Complexity1840
Isotope Atom Count0
Defined Atom Stereocenter Count15
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count4
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Inflammatory Agents

Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)


Immunosuppressive Agents

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)


ABOUT THIS PAGE

Looking for 851536-75-9 / Umirolimus API manufacturers, exporters & distributors?

Umirolimus manufacturers, exporters & distributors 1

52

PharmaCompass offers a list of Umirolimus API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Umirolimus manufacturer or Umirolimus supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Umirolimus manufacturer or Umirolimus supplier.

PharmaCompass also assists you with knowing the Umirolimus API Price utilized in the formulation of products. Umirolimus API Price is not always fixed or binding as the Umirolimus Price is obtained through a variety of data sources. The Umirolimus Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Umirolimus

Synonyms

Biolimus a9, Trm 986, Trm-986, 42-o-(2-ethoxyethyl) rapamycin, 40-o-(2-ethoxyethyl)rapamycin, 851536-75-9

Cas Number

851536-75-9

Unique Ingredient Identifier (UNII)

U36PGF65JH

Umirolimus Manufacturers

A Umirolimus manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Umirolimus, including repackagers and relabelers. The FDA regulates Umirolimus manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Umirolimus API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Umirolimus Suppliers

A Umirolimus supplier is an individual or a company that provides Umirolimus active pharmaceutical ingredient (API) or Umirolimus finished formulations upon request. The Umirolimus suppliers may include Umirolimus API manufacturers, exporters, distributors and traders.

click here to find a list of Umirolimus suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Umirolimus USDMF

A Umirolimus DMF (Drug Master File) is a document detailing the whole manufacturing process of Umirolimus active pharmaceutical ingredient (API) in detail. Different forms of Umirolimus DMFs exist exist since differing nations have different regulations, such as Umirolimus USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Umirolimus DMF submitted to regulatory agencies in the US is known as a USDMF. Umirolimus USDMF includes data on Umirolimus's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Umirolimus USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Umirolimus suppliers with USDMF on PharmaCompass.

Umirolimus NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Umirolimus as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Umirolimus API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Umirolimus as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Umirolimus and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Umirolimus NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Umirolimus suppliers with NDC on PharmaCompass.

Umirolimus GMP

Umirolimus Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Umirolimus GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Umirolimus GMP manufacturer or Umirolimus GMP API supplier for your needs.

Umirolimus CoA

A Umirolimus CoA (Certificate of Analysis) is a formal document that attests to Umirolimus's compliance with Umirolimus specifications and serves as a tool for batch-level quality control.

Umirolimus CoA mostly includes findings from lab analyses of a specific batch. For each Umirolimus CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Umirolimus may be tested according to a variety of international standards, such as European Pharmacopoeia (Umirolimus EP), Umirolimus JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Umirolimus USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty